SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21085)5/19/1998 8:21:00 AM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
So is tonyt - Hank Hill or Go Lgnd? Or both.



To: Henry Niman who wrote (21085)5/19/1998 8:36:00 AM
From: Hippieslayer  Read Replies (2) | Respond to of 32384
 
LA times--today's issue-- has a front page article on Raloxifene withthe headline of "Osteoporosis Drug Found to CUt Breast Cancer Risk"



To: Henry Niman who wrote (21085)5/19/1998 10:38:00 AM
From: RXGOLF  Read Replies (3) | Respond to of 32384
 
<<I've read nothing but good news about LGND, so why is it still below $14.
Is there something wrong? I just heard that H&Q lowered its earnings estimate for
next year by 70c
--Tony >>

Sounds very familiar, but I can't place where I've seen this same sort of misrepresentation of information before! Can anyone else finger where this might be coming from? It sure looks like someone is trying to drive down the price for some reason!!!!!!!!!!!!

Shssss,
Greg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News